VCBB faculty member, Ela Knapik, and team discover a new genetic disease and molecular mechanism.
VCBB faculty member, Jeff Nyman, was featured in the VUMC Reporter.
VCBB faculty member, Rachelle Johnson, was awarded a VICC Discovery Grant for a collaboration with Dr. Micheal King (VU).
VCBB faculty member, Jeff Nyman's, research was recently featured on VUMC Discover.
VCBB graduate student Erik Beadle (Sterling Lab) was nominated and selected as the featured alumni from his former biology program at Louisiana Tech University.
VCBB graduate student Tolu Omokehinde and his mentor Rachelle Johnson received a 2018 Howard Hughes Medical Institute (HHMI) Gilliam Fellowship. The fellowship is committed to promoting diversity and inclusivity in the graduate setting.
Mustafa Unal received the Ten Outstanding Young Persons (TOYP) in 2017 award from JCI Turkiye for Medical Innovation. His receipt of the award was also recognized by his alma mater, Case Western Reserve University.
by Bill Sneider | Reporter, Thursday, Jun. 15, 2017 10:33 AM
Unal and Nyman currently are translating Raman spectroscopy from a powerful laboratory tool into a useful and practical diagnostic instrument for bone evaluations.
by Tom Wilemon | Reporter, Thursday, Oct. 20, 2016 8:56 AM
“We hope to find relevant biomarkers directly from bones that will tell doctors, ‘Yes, this particular individual is having issues with his or her bone matrix and maybe needs to be treated,’” Nyman said.
by Christina Echegaray | Reporter, Thursday, Jul. 21, 2016, 11:08 AM
“Even adult patients who have learned to live with chronic pain, difficulty with mobility and frequent and non-healing fractures are now benefiting from the medication. This story being picked up by PBS has also served to impact other patients,” Dr. Simmons said.
by Leigh MacMillan | Thursday, Oct. 1, 2015, 10:12 AM
“It’s intriguing that a therapy designed for a small population — patients with FOP — may actually benefit a much larger group,” Hong said. “One of the joys of research is discovering and developing something that has the potential to impact human lives.”
by Dagny Stuart | Reporter, Thursday, Sept. 24, 2015 10:33 AM
“Even if this doesn’t cure the patient, we are trying to develop and deliver therapies that have a significant chance of giving patients more quality time,” Sterling said.
by Leigh MacMillan | Thursday, Aug. 7, 2014, 9:17 AM
“I think we’ve made great progress in this area,” Elefteriou said. “It’s exciting that instead of fixing the bones after they break, we might have a drug now to prevent the fractures.”
by David Salisbury | Oct. 2, 2013, 3:18 PM
“We know that this is just one small step in a long process, but we hope that PoraDerm will ultimately be used widely in the nation’s hospitals to help patients recover from their wounds,” said Harmata.
by Leigh MacMillan | Thursday, Jun. 20, 2013, 9:13 AM
“We think a really interesting therapeutic strategy for this compound is that it might augment the antimicrobial activity of existing classes of antibiotics by preventing resistance to them — it might extend the lifetime of these classes of antibiotics,” Skaar said.
by Leigh MacMillan | Wednesday, Jul. 18, 2012, 7:59 AM
“If something as simple as a beta blocker could prevent cancer metastasis to bone, this would impact the treatment of millions of patients worldwide,” [Elefteriou] said.